Posted Sep. 14, 2017 at 6:30 a.m.

Premium Lock Durham pharma firm's stock pops 23% in move to Nasdaq (+ video)

Published: 2017-09-14 06:30:35
Updated: 2017-09-14 06:30:35

Fennec Pharma  Fennec Pharma

Drug development company Fennec Pharmeuticals Inc. saw its stock price rise by more than 23 percent in its first day of trading on the Nasdaq. Plus: Watch a video about Fennec's clinical trial of a possible treatment for hearing loss in children undergoing chemotherapy....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 The University of North Carolina at Chapel Hill. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders